NCT00208416

Brief Summary

The purpose of this study is to compare the short-term outcomes of two surgical techniques, minimally invasive and conventional, when used in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be randomly allocated to undergo surgery using the minimally invasive or conventional surgical technique and will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments with a focus on short term rehabilitation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Oct 2005

Longer than P75 for phase_4

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 13, 2005

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 21, 2005

Completed
10 days until next milestone

Study Start

First participant enrolled

October 1, 2005

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2007

Completed
6.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2014

Completed
Last Updated

May 11, 2016

Status Verified

March 1, 2016

Enrollment Period

2.2 years

First QC Date

September 13, 2005

Last Update Submit

May 9, 2016

Conditions

Keywords

HipSurgical Technique

Outcome Measures

Primary Outcomes (4)

  • Number of hours post-operatively after which subjects are first able to mobilise with a frame or crutches

    First post-operative day

  • Level of assistance required to perform 3 functional tasks (supine to sit, sit to stand and bed to chair transfer)on the second post-operative day

    Second post-operative day

  • Time taken (in seconds) for subjects to walk 10 metres on the second post-operative day.

    Second post-operative day

  • Amount of time (in seconds) for which subjects are able to stand on the operative leg on the second post-operative day.

    Second post-operative day

Secondary Outcomes (8)

  • Haematological parameters assessed over a 56 hours post op

    56 hours post-operatively

  • Pain levels and wound condition

    Until discharge

  • Trendelenberg sign

    Until discharge and at 6 weeks

  • Day of discharge

    Until discharge

  • Activity levels over specified distances

    Until discharge

  • +3 more secondary outcomes

Study Arms (2)

1

ACTIVE COMPARATOR

DePuy MI System

Procedure: DePuy MI System

2

ACTIVE COMPARATOR

Conventional surgical technique

Procedure: Conventional surgical technique

Interventions

A minimally invasive surgical technique used in total hip replacement.

1

A conventional surgical technique used in total hip replacement

2

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • i) Male or female subjects, aged between 18 and 75 years inclusive.
  • ii) Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained.
  • iii) Subjects who in the opinion of the Investigator, are able to understand this investigation, co-operate with the investigational procedures and are willing to return to the hospital for all the required post-operative follow-ups.
  • iv) Subjects with a primary diagnosis of osteoarthritis.
  • v) Subjects considered suitable for a primary total hip arthroplasty and are considered suitable for a minimally invasive surgical procedure.

You may not qualify if:

  • i) Subjects who, in the opinion of the Investigator, have an existing condition that would compromise their participation and follow-up in this study, or extend their time to discharge beyond that required for their hip replacement surgery.
  • ii) Women who are pregnant.
  • iii) Subjects who are known drug or alcohol abusers or with psychological disorders that could effect follow-up care or treatment outcomes.
  • iv) Subjects who have participated in a clinical study with an investigational product in the last 6 month(s).
  • v) Subjects who are currently involved in any injury litigation claims.
  • vi) Subjects with a Body Mass Index (BMI) \> 30.
  • vii) Subjects with a malunion, arthrodesis or severe dysplasia with superior femoral head migration.
  • viii) Subjects requiring a simultaneous bilateral total hip arthroplasty.
  • ix) Subjects undergoing the second stage of a staged bilateral who are less than 9 months post-arthroplasty

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Rotherham General Hospitals NHS Trust

Rotherham, South Yorkshire, United Kingdom

Location

Warwick Hospital NHS Trust

Warwick, United Kingdom

Location

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 13, 2005

First Posted

September 21, 2005

Study Start

October 1, 2005

Primary Completion

December 1, 2007

Study Completion

November 1, 2014

Last Updated

May 11, 2016

Record last verified: 2016-03

Locations